| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Farhan J. Ahmad | Q42182005 |
| P2093 | author name string | G K Jain | |
| R K Khar | |||
| S Akhter | |||
| N Mallick | |||
| S A Pathan | |||
| M H Warsi | |||
| P2860 | cites work | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 |
| Effect of gene therapy on visual function in Leber's congenital amaurosis | Q28277981 | ||
| Gene delivery to cornea. | Q30476991 | ||
| In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye. | Q30706189 | ||
| Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer | Q30803063 | ||
| In vivo gene transfer into choroidal neovascularization by the HVJ liposome method | Q30858056 | ||
| Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. | Q31142871 | ||
| Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. | Q33207041 | ||
| Aptamers: an emerging class of therapeutics | Q33211036 | ||
| Efficient non-viral ocular gene transfer with compacted DNA nanoparticles | Q33267297 | ||
| Gene therapy targeting glaucoma: where are we? | Q33763673 | ||
| Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery. | Q33837747 | ||
| In vivo gene delivery in the retina using polyethylenimine | Q33914306 | ||
| Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides | Q33916110 | ||
| Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea | Q34093606 | ||
| A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo | Q34093683 | ||
| Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres | Q34167627 | ||
| Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease | Q34499843 | ||
| Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis | Q35103511 | ||
| Recent developments in ocular gene therapy | Q35125708 | ||
| Long-lasting secretion of transgene product from differentiated and filter-grown retinal pigment epithelial cells after nonviral gene transfer | Q46601353 | ||
| RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice | Q46966325 | ||
| Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung | Q47331709 | ||
| Scleral permeability of a small, single-stranded oligonucleotide. | Q51681486 | ||
| Structure–activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery | Q58050663 | ||
| Sustained release of nanosized complexes of polyethylenimine and anti-TGF-β2 oligonucleotide improves the outcome of glaucoma surgery | Q63347527 | ||
| Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system | Q68417065 | ||
| Gene transfer to the retina of rat by liposome eye drops | Q71113540 | ||
| Delivery of antisense oligonucleotide to the cornea by iontophoresis | Q73518928 | ||
| Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells | Q73898475 | ||
| Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats | Q74313379 | ||
| Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms | Q77812948 | ||
| Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis | Q80219462 | ||
| Aptamers--basic research, drug development, and clinical applications | Q36311540 | ||
| Non-viral ocular gene therapy: potential ocular therapeutic avenues. | Q36649192 | ||
| Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. | Q36649938 | ||
| New cationic lipid formulations for gene transfer | Q36841020 | ||
| Corneal gene therapy | Q36913747 | ||
| Nanoparticle applications in ocular gene therapy | Q36933896 | ||
| Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics | Q36937189 | ||
| Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery | Q37127602 | ||
| Mechanism of oligonucleotide release from cationic liposomes | Q37255679 | ||
| Recent perspectives in ocular drug delivery | Q37256549 | ||
| Gene delivery to the retina: focus on non-viral approaches | Q37313552 | ||
| Ocular gene therapy: current progress and future prospects | Q37355359 | ||
| Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy | Q37607034 | ||
| Introduction: Understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration | Q37607656 | ||
| Nanoparticles for retinal gene therapy | Q37746102 | ||
| Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. | Q39977757 | ||
| Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. | Q39988321 | ||
| Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). | Q40311774 | ||
| Nanoparticles for gene delivery to retinal pigment epithelial cells. | Q40442338 | ||
| Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. | Q40534332 | ||
| Antisense oligonucleotides as therapeutic agents--is the bullet really magical? | Q40834751 | ||
| Cell delivery and mechanisms of action of antisense oligonucleotides | Q40876347 | ||
| A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides | Q40886492 | ||
| Physico-chemical characterization and transfection efficacy of cationic liposomes containing the pEGFP plasmid | Q42167502 | ||
| Gene transfer with liposomes to the intraocular tissues by different routes of administration. | Q42521684 | ||
| Improved anti-herpes simplex virus type 1 activity of a phosphodiester antisense oligonucleotide containing a 3'-terminal hairpin-like structure | Q43504689 | ||
| Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes | Q43628859 | ||
| In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles | Q43662967 | ||
| Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. | Q43843378 | ||
| Widespread expression of an exogenous gene in the eye after intravenous administration. | Q44119141 | ||
| Nanoparticles of compacted DNA transfect postmitotic cells | Q44478822 | ||
| Ultrapure chitosan oligomers as carriers for corneal gene transfer | Q44535494 | ||
| Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer | Q44613306 | ||
| In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits | Q44935883 | ||
| Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide | Q45226190 | ||
| Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model | Q45259635 | ||
| Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. | Q45857735 | ||
| Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides. | Q45858295 | ||
| Gene therapy for ocular neovascularization: a cure in sight | Q45862681 | ||
| Polyplex-mediated gene transfer into human retinal pigment epithelial cells in vitro | Q45863670 | ||
| Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells | Q45869492 | ||
| Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. | Q45885254 | ||
| Real-time imaging of gene delivery and expression with DNA nanoparticle technologies. | Q45885773 | ||
| Subcutaneous peripheral injection of cationized gelatin/DNA polyplexes as a platform for non-viral gene transfer to sensory neurons. | Q46002594 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 675-688 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Indian Journal of Pharmaceutical Sciences | Q6020807 |
| P1476 | title | Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics | |
| P478 | volume | 72 |
Search more.